Biogenic amine testing in the South African public health care system
Background: Phaeochromocytoma, paraganglioma and neuroblastoma are catecholamine secreting neuroendocrine tumours. Biochemical screening for suspected cases of these tumours involves the measurement of catecholamines and their metabolites in either urine or plasma. The South African National Health...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Practical Laboratory Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352551725000101 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850059778651324416 |
|---|---|
| author | D. Legg-E’Silva E.M. Cave T. Snyman S. Currin N. Kone K.L. Prigge |
| author_facet | D. Legg-E’Silva E.M. Cave T. Snyman S. Currin N. Kone K.L. Prigge |
| author_sort | D. Legg-E’Silva |
| collection | DOAJ |
| description | Background: Phaeochromocytoma, paraganglioma and neuroblastoma are catecholamine secreting neuroendocrine tumours. Biochemical screening for suspected cases of these tumours involves the measurement of catecholamines and their metabolites in either urine or plasma. The South African National Health Laboratory service (NHLS) measures urine fractionated metanephrines (UMF) and normetanephrines (UNF), urine vanillylmandelic acid (UVMA) and urine homovanillic acid (UHVA). Objectives: To analyse the demographic, biochemical and testing patterns of patients’ UMF, UNF, UVMA and UHVA in the NHLS. Methods: Data from January 2015 to December 2016 for all patients undergoing UMF, UNF, UVMA and UHVA testing was extracted from the NHLS central data warehouse. Neuroendocrine tumours were biochemically diagnosed when results were >2x multiples of the upper reference limits. Multiple testing was defined as ≥2 tests within a 14-day period. Ethnicity was determined through hot-deck imputation. Results: Biochemically abnormal test results were identified by UMF/UNF measurements in 98.2 % of cases. In 1.8 % of cases, the addition of UVMA resulted in a previously unidentified biochemical positive. Adult white and coloured populations have significantly less biochemically positive UMF results compared to the African population. Multiple testing resulted in discordant results for 12.8 % of UMF and 13.1 % of UNF testing. Conclusion: UVMA testing for phaeochromocytoma and paraganglioma offers little benefit over testing with UMF alone. Requesting consecutive multiple samples is preferred, however, a single 24-h fractionated UMF/UNF is efficient and cost-effective for phaeochromocytoma and paraganglioma screening, with further testing recommended when clinically indicated. African individuals are more likely to have raised catecholamines and requires further investigation. |
| format | Article |
| id | doaj-art-315b70aaec4a41dc9cf5aa504af5afc1 |
| institution | DOAJ |
| issn | 2352-5517 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Practical Laboratory Medicine |
| spelling | doaj-art-315b70aaec4a41dc9cf5aa504af5afc12025-08-20T02:50:48ZengElsevierPractical Laboratory Medicine2352-55172025-04-0144e0045710.1016/j.plabm.2025.e00457Biogenic amine testing in the South African public health care systemD. Legg-E’Silva0E.M. Cave1T. Snyman2S. Currin3N. Kone4K.L. Prigge5Corresponding author.; Department of Chemical Pathology, University of the Witwatersrand and National Health Laboratory Services, Johannesburg, South AfricaDepartment of Chemical Pathology, University of the Witwatersrand and National Health Laboratory Services, Johannesburg, South AfricaDepartment of Chemical Pathology, University of the Witwatersrand and National Health Laboratory Services, Johannesburg, South AfricaDepartment of Chemical Pathology, University of the Witwatersrand and National Health Laboratory Services, Johannesburg, South AfricaDepartment of Chemical Pathology, University of the Witwatersrand and National Health Laboratory Services, Johannesburg, South AfricaDepartment of Chemical Pathology, University of the Witwatersrand and National Health Laboratory Services, Johannesburg, South AfricaBackground: Phaeochromocytoma, paraganglioma and neuroblastoma are catecholamine secreting neuroendocrine tumours. Biochemical screening for suspected cases of these tumours involves the measurement of catecholamines and their metabolites in either urine or plasma. The South African National Health Laboratory service (NHLS) measures urine fractionated metanephrines (UMF) and normetanephrines (UNF), urine vanillylmandelic acid (UVMA) and urine homovanillic acid (UHVA). Objectives: To analyse the demographic, biochemical and testing patterns of patients’ UMF, UNF, UVMA and UHVA in the NHLS. Methods: Data from January 2015 to December 2016 for all patients undergoing UMF, UNF, UVMA and UHVA testing was extracted from the NHLS central data warehouse. Neuroendocrine tumours were biochemically diagnosed when results were >2x multiples of the upper reference limits. Multiple testing was defined as ≥2 tests within a 14-day period. Ethnicity was determined through hot-deck imputation. Results: Biochemically abnormal test results were identified by UMF/UNF measurements in 98.2 % of cases. In 1.8 % of cases, the addition of UVMA resulted in a previously unidentified biochemical positive. Adult white and coloured populations have significantly less biochemically positive UMF results compared to the African population. Multiple testing resulted in discordant results for 12.8 % of UMF and 13.1 % of UNF testing. Conclusion: UVMA testing for phaeochromocytoma and paraganglioma offers little benefit over testing with UMF alone. Requesting consecutive multiple samples is preferred, however, a single 24-h fractionated UMF/UNF is efficient and cost-effective for phaeochromocytoma and paraganglioma screening, with further testing recommended when clinically indicated. African individuals are more likely to have raised catecholamines and requires further investigation.http://www.sciencedirect.com/science/article/pii/S2352551725000101 |
| spellingShingle | D. Legg-E’Silva E.M. Cave T. Snyman S. Currin N. Kone K.L. Prigge Biogenic amine testing in the South African public health care system Practical Laboratory Medicine |
| title | Biogenic amine testing in the South African public health care system |
| title_full | Biogenic amine testing in the South African public health care system |
| title_fullStr | Biogenic amine testing in the South African public health care system |
| title_full_unstemmed | Biogenic amine testing in the South African public health care system |
| title_short | Biogenic amine testing in the South African public health care system |
| title_sort | biogenic amine testing in the south african public health care system |
| url | http://www.sciencedirect.com/science/article/pii/S2352551725000101 |
| work_keys_str_mv | AT dleggesilva biogenicaminetestinginthesouthafricanpublichealthcaresystem AT emcave biogenicaminetestinginthesouthafricanpublichealthcaresystem AT tsnyman biogenicaminetestinginthesouthafricanpublichealthcaresystem AT scurrin biogenicaminetestinginthesouthafricanpublichealthcaresystem AT nkone biogenicaminetestinginthesouthafricanpublichealthcaresystem AT klprigge biogenicaminetestinginthesouthafricanpublichealthcaresystem |